Myomo (NYSEAMERICAN:MYO) Director Heather Getz Buys 20,000 Shares

Myomo, Inc. (NYSEAMERICAN:MYO) Director Heather Getz acquired 20,000 shares of the stock in a transaction dated Monday, March 16th. The stock was purchased at an average cost of $0.70 per share, with a total value of $14,000.00. Following the purchase, the director directly owned 131,754 shares of the company’s stock, valued at $92,227.80. This trade represents a 17.90% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Myomo Trading Down 2.5%

NYSEAMERICAN:MYO traded down $0.02 during mid-day trading on Tuesday, hitting $0.72. 241,326 shares of the company’s stock were exchanged, compared to its average volume of 501,557. The company has a 50 day simple moving average of $0.83 and a 200-day simple moving average of $0.91. The company has a current ratio of 3.30, a quick ratio of 2.93 and a debt-to-equity ratio of 0.98. Myomo, Inc. has a fifty-two week low of $0.63 and a fifty-two week high of $5.62. The firm has a market capitalization of $27.77 million, a P/E ratio of -1.95 and a beta of 1.17.

Institutional Trading of Myomo

Hedge funds and other institutional investors have recently bought and sold shares of the business. Cubist Systematic Strategies LLC lifted its stake in shares of Myomo by 157.4% in the first quarter. Cubist Systematic Strategies LLC now owns 49,101 shares of the company’s stock valued at $236,000 after buying an additional 30,028 shares in the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Myomo in the first quarter worth approximately $75,000. Jane Street Group LLC lifted its holdings in shares of Myomo by 84.2% in the first quarter. Jane Street Group LLC now owns 162,658 shares of the company’s stock valued at $782,000 after purchasing an additional 74,338 shares in the last quarter. Acadian Asset Management LLC bought a new position in shares of Myomo in the first quarter valued at approximately $114,000. Finally, Geode Capital Management LLC boosted its position in shares of Myomo by 160.8% during the second quarter. Geode Capital Management LLC now owns 669,281 shares of the company’s stock valued at $1,446,000 after buying an additional 412,631 shares during the last quarter. Institutional investors own 44.99% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on MYO shares. Craig Hallum restated a “buy” rating on shares of Myomo in a research report on Tuesday, March 10th. Ascendiant Capital Markets cut their price objective on shares of Myomo from $10.50 to $10.00 and set a “buy” rating on the stock in a research report on Friday, November 21st. Four investment analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $7.67.

About Myomo

Myomo, Inc (NYSE American: MYO) is a medical robotics company specializing in developing and commercializing powered orthotic devices designed to restore mobility and function for individuals with upper-limb weakness. The company’s flagship product, the MyoPro®, is an FDA-cleared, wearable robotic orthosis that leverages proprietary sensors and actuators to detect and amplify users’ own muscle signals, enabling patients with conditions such as stroke, spinal cord injury, muscular dystrophy and other neuromuscular disorders to perform daily activities with greater independence.

Myomo markets the MyoPro through a network of licensed orthotic and prosthetic professionals, clinics and hospitals across North America.